IP-10 is the leading alternative candidate to IFN-γ, and is expressed at 100-fold higher levels relative to IFN-γ, driving improved sensitivity over IGRA especially in immunosuppressed patients with HIV infection and in children33, 34, 35. The gene discussed is IFNG; the disease is HIV infectious disease.